文摘
LPS-stimulated macrophage products (LSMP) may enhance WA-induced apoptosis. WA plus LSMP co-treatment can decrease the expression of pro-caspases-8, pro-caspases-9, pro-caspase-3 and anti-apoptotic proteins (XIAP and cIAP) and increase the cleavage of PARP. WA plus LSMP co-treatment significantly decrease the nuclear NF-κB-p65 levels. Our findings will provide an effective strategy that targets macrophages to enhance the antitumor efficacy of cytotoxic chemotherapy.